Forvis Mazars Wealth Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.78M | Buy |
17,171
+3,121
| +22% | +$279K | 0.03% | 168 |
|
|
2026
Q1 | $1.01M | Sell |
14,050
-728
| -5% | -$56.1K | 0.02% | 209 |
|
|
2025
Q4 | $1.17M | Sell |
14,778
-1,649
| -10% | -$130K | 0.02% | 193 |
|
|
2025
Q3 | $1.24M | Sell |
16,427
-1,667
| -9% | -$114K | 0.02% | 189 |
|
|
2025
Q2 | $1.25M | Buy |
18,094
+104
| +0.6% | +$6.82K | 0.03% | 189 |
|
|
2025
Q1 | $1.22M | Sell |
17,990
-3,946
| -18% | -$236K | 0.03% | 191 |
|
|
2024
Q4 | $985K | Sell |
21,936
-4,562
| -17% | -$256K | 0.02% | 224 |
|
|
2024
Q3 | $1.67M | Sell |
26,498
-852
| -3% | -$49.7K | 0.04% | 181 |
|
|
2024
Q2 | $1.62M | Sell |
27,350
-1,504
| -5% | -$94.1K | 0.04% | 174 |
|
|
2024
Q1 | $2.3M | Buy |
28,854
+2,037
| +8% | +$156K | 0.06% | 150 |
|
|
2023
Q4 | $2.12M | Buy |
26,817
+475
| +2% | +$33.8K | 0.06% | 151 |
|
|
2023
Q3 | $1.84M | Sell |
26,342
-12,437
| -32% | -$881K | 0.06% | 154 |
|
|
2023
Q2 | $2.68M | Buy |
38,779
+15,062
| +64% | +$1.07M | 0.08% | 144 |
|
|
2023
Q1 | $1.76M | Buy |
23,717
+990
| +4% | +$83K | 0.06% | 158 |
|
|
2022
Q4 | $2.12M | Buy |
22,727
+771
| +4% | +$74.4K | 0.07% | 140 |
|
|
2022
Q3 | $2.09M | Buy |
21,956
+1,284
| +6% | +$127K | 0.08% | 135 |
|
|
2022
Q2 | $1.92M | Sell |
20,672
-448
| -2% | -$43.7K | 0.08% | 131 |
|
|
2022
Q1 | $2.14M | Buy |
21,120
+1,768
| +9% | +$186K | 0.09% | 104 |
|
|
2021
Q4 | $2M | Buy |
19,352
+730
| +4% | +$67.5K | 0.08% | 102 |
|
|
2021
Q3 | $1.58M | Buy |
18,622
+26
| +0.1% | +$2.18K | 0.07% | 113 |
|
|
2021
Q2 | $1.55M | Sell |
18,596
-527
| -3% | -$43.2K | 0.07% | 114 |
|
|
2021
Q1 | $1.44M | Sell |
19,123
-2,559
| -12% | -$186K | 0.07% | 113 |
|
|
2020
Q4 | $1.48M | Buy |
21,682
+3,932
| +22% | +$256K | 0.07% | 122 |
|
|
2020
Q3 | $1.04M | Buy |
17,750
+1,315
| +8% | +$81.8K | 0.06% | 132 |
|
|
2020
Q2 | $1.07M | Buy |
16,435
+3,542
| +27% | +$223K | 0.07% | 126 |
|
|
2020
Q1 | $765K | Buy |
12,893
+3,148
| +32% | +$210K | 0.06% | 131 |
|
|
2019
Q4 | $724K | Buy |
9,745
+2,753
| +39% | +$193K | 0.05% | 147 |
|
|
2019
Q3 | $441K | Sell |
6,992
-3,763
| -35% | -$223K | 0.04% | 188 |
|
|
2019
Q2 | $586K | Sell |
10,755
-2,597
| -19% | -$140K | 0.05% | 148 |
|
|
2019
Q1 | $720K | Buy |
13,352
+6,210
| +87% | +$383K | 0.06% | 127 |
|
|
2018
Q4 | $468K | Buy |
7,142
+705
| +11% | +$52.6K | 0.05% | 140 |
|
|
2018
Q3 | $507K | Buy |
6,437
+25
| +0.4% | +$1.79K | 0.04% | 144 |
|
|
2018
Q2 | $413K | Buy |
6,412
+482
| +8% | +$31.8K | 0.04% | 163 |
|
|
2018
Q1 | $369K | Sell |
5,930
-96
| -2% | -$6.89K | 0.04% | 181 |
|
|
2017
Q4 | $437K | Sell |
6,026
-993
| -14% | -$72.2K | 0.04% | 163 |
|
|
2017
Q3 | $571K | Buy |
7,019
+722
| +11% | +$57.1K | 0.06% | 124 |
|
|
2017
Q2 | $507K | Buy |
6,297
+364
| +6% | +$28.7K | 0.06% | 137 |
|
|
2017
Q1 | $466K | Buy |
5,933
+158
| +3% | +$12.6K | 0.06% | 129 |
|
|
2016
Q4 | $456K | Sell |
5,775
-218
| -4% | -$17.6K | 0.06% | 128 |
|
|
2016
Q3 | $533K | Sell |
5,993
-1,992
| -25% | -$188K | 0.07% | 110 |
|
|
2016
Q2 | $764K | Sell |
7,985
-169
| -2% | -$16.8K | 0.11% | 86 |
|
|
2016
Q1 | $846K | Sell |
8,154
-426
| -5% | -$41.4K | 0.14% | 81 |
|
|
2015
Q4 | $839K | Buy |
8,580
+1,167
| +16% | +$114K | 0.13% | 80 |
|
|
2015
Q3 | $715K | Buy |
7,413
+2,281
| +44% | +$240K | 0.13% | 82 |
|
|
2015
Q2 | $538K | Sell |
5,132
-199
| -4% | -$20.3K | 0.08% | 98 |
|
|
2015
Q1 | $550K | Buy |
5,331
+519
| +11% | +$52.5K | 0.08% | 102 |
|
|
2014
Q4 | $463K | Buy |
4,812
+981
| +26% | +$86.4K | 0.08% | 101 |
|
|
2014
Q3 | $305K | Hold |
3,831
| – | – | 0.05% | 109 |
|
|
2014
Q2 | $289K | Sell |
3,831
-275
| -7% | -$20.8K | 0.05% | 115 |
|
|
2014
Q1 | $309K | Buy |
4,106
+8
| +0.2% | +$565 | 0.05% | 125 |
|
|
2013
Q4 | $293K | Sell |
4,098
-54
| -1% | -$3.47K | 0.05% | 128 |
|
|
2013
Q3 | $236K | Sell |
4,152
-90
| -2% | -$5.36K | 0.05% | 129 |
|
|
2013
Q2 | $243K | Buy |
+4,242
| New | +$246K | 0.19% | 88 |
|
Other funds holding CVS
Forvis Mazars Wealth Advisors's CVS Position: Q2 2026 in Review
Forvis Mazars Wealth Advisors increased its CVS Health (CVS) stake by 22% in Q2 2026, buying an estimated $279K and bringing the position to 17,171 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #168.
Forvis Mazars Wealth Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.68M in Q2 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Forvis Mazars Wealth Advisors held 17,171 shares of CVS Health worth $1.78M as of Q2 2026.
- Forvis Mazars Wealth Advisors bought 3,121 CVS Health shares in Q2 2026, an estimated $279K.
- CVS Health made up 0.03% of Forvis Mazars Wealth Advisors's portfolio in Q2 2026, its #168 holding.
- Forvis Mazars Wealth Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Forvis Mazars Wealth Advisors's CVS Health position peaked at $2.68M in Q2 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.